SIGNALING through the evolutionarily conserved insulin pathway is critical for organismal homeostasis, controlling everything from growth regulation and development to metabolic homeostasis through glucose and lipid metabolism. In mammals, insulin synthesis and release takes place in pancreatic β-cells. Insulin production is regulated by many factors such as nutrient status and hormonal signals ([@bib70]). After translation, insulin is packaged into dense-core vesicles (DCVs) and trafficked to the plasma membrane. Transport of insulin-containing DCVs is microtubule dependent, and the microtubule motor kinesin-1 is known to influence insulin granule transport ([@bib66]; [@bib94]). DCV transport is additionally regulated by Rab27a. Through its effectors Slac2c, Noc2, Slp4, Exophilin8, and coronin3, Rab27a regulates movement of DCVs and their docking and fusion to the plasma membrane ([@bib110]; [@bib51]; [@bib58]; [@bib57]; [@bib104]). DCV release is modulated largely via glucose stimulation and internalization, resulting in increased β-cell ATP levels. This induces the closure of ATP-dependent potassium channels and cell depolarization, triggering an influx of calcium ions through voltage-dependent calcium channels. Ca^2+^ promotes formation of the SNARE complex, allowing DCV fusion and insulin release ([@bib50]). Thus, proper packaging, trafficking, and exocytosis of insulin-containing DCVs is central to regulating insulin secretion. Defects in insulin production and trafficking arise early in the pathogenesis of diabetes. Many factors involved in DCV trafficking and the molecular details of DCV release remain elusive.

Research in animal models, in particular in *Drosophila* with its large genetic toolkit and fast generation time, can provide mechanistic insights into insulin-like peptide (ILP) production and DCV transport and release. *Drosophila* ILPs are homologous to human and mouse insulin/insulin-like growth factors ([@bib12]). Deletion of *Ilps 1-5* results in smaller flies with lower metabolic activity ([@bib113]), while ubiquitous overexpression of *Ilp2* is sufficient to promote growth ([@bib43]). In flies, ILPs are produced and secreted mainly by insulin-producing cells (IPCs) in the brain to control growth and metabolism ([@bib43]; [@bib85]). ILP secretion is dependent on autonomous regulation and on inputs received from other cellular populations ([@bib17]; [@bib30]; [@bib7]; [@bib80]). ILPs are also produced by fat body cells during the pupal nonfeeding stages ([@bib74]; [@bib90]). Flies that lack IPCs have delayed development, reduced growth, and increased circulating sugar levels ([@bib85]), suggesting that IPCs in flies play a role comparable to β-cells in mammals.

IPCs number only 14 of ∼100,000 neurons. They develop from a single pair of neuroblasts in the anterior neuroectoderm during late embryogenesis ([@bib106]). During larval stages, IPCs secrete ILPs to promote growth and regulate sugar metabolism, while concurrently undergoing morphological development. Although the morphological development of IPCs during larval stages has not been well characterized, their neuronal processes extend through the brain to the aorta and the corpora cardiac compartment of the ring gland for ILP release ([@bib85]). Adult IPCs are important for regulating starvation resistance, responding to oxidative and temperature stress, and adjusting carbohydrate and lipid metabolism ([@bib69]).

The long neurites of larval and adult IPCs suggest that ILPs require extensive intracellular transport to reach secretion sites, the mechanism of which is largely unexplored. To identify additional cellular components that are important for insulin secretion *in vivo*, we sequenced messenger RNA (mRNA) purified from IPCs and identified IPC-enriched gene expression. To obtain a relatively pure population of fly IPCs for mRNA extraction, we used laser-capture microdissection (LCM). Compared with other cell- and tissue-specific RNA isolation techniques for *Drosophila*, including FACS ([@bib97]), magnetic bead-based cell purification ([@bib46]), and RNA-binding protein-based strategies ([@bib68]), LCM has advantages for isolating specific cell types, especially for cells that are clustered, like IPCs. LCM has a reasonably high degree of spatial resolution and accuracy ([@bib45]). We first characterized the temporal development of IPCs in detail and analyzed the transcriptome of early third instar IPCs. We identified 193 genes as enriched in IPCs, in comparison to randomly captured neurons, and found that many orthologous genes are active in mammalian pancreatic β-cells. In parallel, we tested 31 YFP-tagged dominant-negative (DN) Rab proteins ([@bib114]) for genes involved in ILP transport. Rab proteins, members of the family of Ras-like GTPases, control many cellular trafficking paths ([@bib93]). Our two approaches identified two genes essential in *Drosophila* for proper trafficking and secretion of ILP-containing DCVs. Here we identify Rab1 as necessary in IPCs to modulate ILP secretion. We discovered a novel function for Unc-104/Kif1a, a kinesin-3 microtubule motor previously known to transport synaptic vesicles ([@bib73]; [@bib75]; [@bib9]), in the transport of DCVs along the axons of IPCs.

Materials and Methods {#s1}
=====================

Fly strains and genetics {#s2}
------------------------

Fly lines used are listed in [Supporting Information](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-12.pdf), [Table S6](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-13.pdf). The temperature shift for Gal80^ts^ experiments was conducted in the following way: Embryos were collected on a molasses cap within a 4-hr period at 25° followed by 40-hr incubation at 18°. Thirty newly hatched first instar larvae were then transferred to each vial, kept at 18° for another 4 days, and shifted to 29° for 24 hr before dissection. Fly food (2×: 3.4% yeast, 8.3% cornmeal, 6% sucrose, 1% agar) was used to raise flies ([@bib30]).

Laser microdissection {#s3}
---------------------

The method was adapted from [@bib92]). Early third instar larval brains were dissected and quickly aligned and frozen with optimal cutting temperature compound (Tissue Tek). We sectioned from the posterior end of the mouth hook to the posterior end of the brain lobes, the position of which was marked by the anterior end of a pupa at one end of the block. A dehydration series (distilled H~2~O for 1 min, 50% ethanol for 30 sec, 70% ethanol for 30 sec, 95% ethanol for 30 sec, 100% ethanol for 30 sec, 100% ethanol for 2 min, xylene for 2 min, xylene for 5 min) was conducted before each section (10 μm thick) was examined under fluorescence with a 20× objective to identify sections that contain IPCs. IPCs were marked by expression of a genetically encoded GFP reporter (an *Ilp2-Gal4* driving a *UAS-mCD8-GFP* reporter gene). In addition, *UAS-nuclear red fluorescent protein* (RFP) was included in the same fly line to independently label IPC cell bodies with RFP. This double labeling of IPCs, together with strong expression of mCD8-GFP (two copies) in these neurons, significantly sped up the process and reliability of IPC identification in cryosections. IPC-enriched samples were captured into PCR tube caps on a Leica LCM microscope (model ASLMD) using Laser Microdissection software version 4.4.

RNA isolation, amplification, and mRNA sequencing library construction {#s4}
----------------------------------------------------------------------

Total RNA of laser-captured samples was extracted using Arcturus PicoPure RNA Isolation Kit (Molecular Devices). mRNA was amplified in two rounds using the Arcturus RiboAmp HS PLUS Amplication Kit (Molecular Devices). Amplified mRNA from each sample was fragmented to 100--200 nt using 10× RNA fragmentation buffer (Ambion). Fragmented RNAs were ligated to the 3′ linker ("Linker-1," IDT Inc.) and 5′ linker \[5′-ACGCTCTTCCGATCTv-3′ (uppercase, DNA; v, barcodes with four RNA molecules: cugg, cguc, acuu, or cccu (IDT Inc.)\]. Complementary DNA (cDNA) was amplified with 18 PCR cycles, using forward primer 5′-GAT ACG GCG ACC ACC GAG ATC TAC ACT CTT TCC CTA CAC GAC GCT CTT CCG ATC T-3′ and reverse primer 5′-CAA GCA GAA GAC GGC ATA CGA GCT CTT CCG ATC TAT TGA TGG TGC CTA CAG-3′ to produce sequencing libraries for the Illumina GA II sequencing system. The details of the RNA library construction protocol are available in [File S5](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-2.pdf).

For whole brain (*Elav-Gal4 \> w^1118^*), total RNA from third instar larval brains was extracted using Trizol (Invitrogen) following the manufacturer's instructions. No mRNA amplification was used. mRNA sequencing libraries were constructed using a TruSeq RNA sample preparation kit (Illumina).

Mapping sequencing reads and mRNA profiling {#s5}
-------------------------------------------

Barcode splitting was performed on the FASTQ file. The first four bases of each read were compared to the barcodes, and up to one mismatch was allowed in the barcode bases. After barcode splitting and read segregation, each mRNA sample was aligned using tophat (version 2.0.0) ([@bib98]), with default parameters against the reference *Drosophila melanogaster* genome and transcriptome \[dm3/BDGP Release 5, from the University of California at Santa Cruz (UCSC) Genome Browser\] ([@bib1]; [@bib29]). Next, cuffdiff in the cufflinks package was used to determine differentially expressed genes and transcripts between the IPC replicates and the control replicates ([@bib99]), where Reads Per Kilobase of exon model per Million mapped reads (RPKM) was calculated for each gene/transcript in each cell type and compared with each other.

Database for Annotation, Visualization and Integrated Discovery functional annotation analysis {#s6}
----------------------------------------------------------------------------------------------

Functional annotation of 193 IPC-enriched transcripts was carried out using the Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 ([@bib39],[@bib40]). Entrez_IDs of the 193 genes were used as input. A total of 191 of 193 Entrez_IDs were annotated as known *Drosophila* genes by DAVID. Among the 191 known *Drosophila* genes, 115 (60.2%) genes have biological function annotations in the GOTERM_BP_FAT database. Annotation categories were searched and clustered using GOTERM_BP_FAT databases. Biological functional clusters were ranked based on an enrichment score, which was statistically measured by Fisher's exact test in DAVID.

Searching mouse homologs of fly genes {#s7}
-------------------------------------

Mouse homologs of IPC-enriched genes were found in the National Center for Biotechnology Information (NCBI) HomoloGene Database Release 66 (<http://www.ncbi.nlm.nih.gov/homologene/>). This method identified mouse orthologs of 104 IPC-enriched genes (193 in total). In addition, five homolog pairs (*Ilp2-Ins1*, *Ilp3-Ins1*, *Ilp5-Ins2*, *ia2-IA2*, *foxo-Foxo1*) were added based on literature information ([@bib12]) and a BLAT (UCSC genome browser) homologous sequence search.

Fly tissue fixation and immunofluorescence {#s8}
------------------------------------------

Fly brains or fat bodies were dissected in ice-cold PBS containing 0.1% Triton X-100 (PBST), and tissues (brains or fat bodies) were fixed in 4% paraformaldehyde for 20 min, followed by extensive washes with PBST. Five-percent normal goat serum (NGS) (Sigma, diluted in PBST) was added to fixed samples for 1 hr at room temperature for blocking. Subsequently, after washing out the NGS, primary antibodies \[rat anti-ILP2 (Pierre Leopold); chick anti-GFP (Aves Labs); rabbit anti-mCherry/mtdTomato/dsRed (Clontech); rabbit anti-β-galactosidase (MP Biomedicals)\] were diluted in 5% NGS and incubated with the samples at 4° overnight. After extensive washes with PBST, secondary antibodies (anti-rat Alexa 488, anti-rat Alexa633, anti-chick Alexa 488, and anti-rabbit Alexa 647) (Invitrogen) were diluted in 5% NGS and incubated with samples at 4° overnight. After PBST washes, samples were mounted in SlowFade Gold antifade reagent (Invitrogen) for slide preparation.

Fly weighing and pupae volume measurement {#s9}
-----------------------------------------

Embryos were collected on a molasses cap within a 4-hr period followed by a 24-hr incubation at 25°. Thirty newly hatched first instar larvae were then transferred to each vial and stayed at 29° until eclosion. Adult males (1--2 days after eclosion) from each vial (typically in groups of 10--20) were weighed on an analytic balance accurate to ±0.01 mg (Mettler Toledo). In the cases where balancer exists for the UAS-RNA interference (RNAi) lines or few adults emerged from each vial, males from multiple vials were combined for weighing.

Pupae were photographed. Pupae length (*L*) and diameter (*D*) were measured using ImageJ. *Drosophila* pupae are assumed to take the shape of an ellipsoid, and their volume could be estimated based on this shape. Pupae volume (*V*) was calculated using the following formula: *V* = (4/3) × 3.14159 × (*D*/2)^2^ × (*L*/2).

Trehalose and glucose measurement {#s10}
---------------------------------

Trehalose assay was performed as previously described ([@bib85]). In brief, hemolymph---circulatory fluid in arthropods---from five to eight larvae was collected by tearing the cuticles and allowing the hemolymph to bleed out and pool on a siliconized glass slide. Hemolymph samples (0.5 μl) as well as trehalose and glucose standards were diluted in 100 μl of Infinity Glucose Reagent (Sigma), and 40 μl of the diluted hemolymph was mixed with 80 μl of Infinity Glucose Reagent with porcine trehalase added at 3 μl/ml in 96-well plates. After a 16- to 18-hr incubation at 37°, plates were read on a fluorescence plate reader (Bio-Tek Instruments model \#FL600). Excitation was applied at 360 nm while emission occurred at 460 nm. Standard curves were generated for determining the combined glucose and trehalose concentration in hemolymph samples.

Quantitative RT-PCR {#s11}
-------------------

For each genotype, 3 × 10 third instar larval brains were collected and RNA was purified using RNAsy kit (Qiagen) according to the manufacturer's instructions. RNA concentration was measured using a NanoDrop 2000 spectrophotometer (Thermo Scientific). cDNA was synthesized from 1 μg RNA using a high-capacity cDNA reverse transcription kit (Applied Biosystems). Quantitative PCR (qPCR) reactions for each biological sample were carried out in duplicate using Taqman assays (Applied Biosystems) for *Ilp2* and *Rpl32*. mRNA levels were compared between conditions using the ΔΔCt method.

Confocal microscopy and image quantifications {#s12}
---------------------------------------------

Fly and pupae images were captured using a Leica MZ FLIII fluorescenct dissecting microscope and a Leica DFC 500 camera. Images were acquired using a TCS SP2 confocal microscope (Leica) with a ×63/numerical aperture 1.4 oil-immersion objective. To quantify ILP2 levels, confocal Z-series of the IPCs were obtained at 1 μm step size with identical laser power and scanning settings between control and experimental samples. Image stacks were then projected into a Z-stack (sum intensity), and the mean fluorescence intensities across IPC cell bodies or fat body nuclei were measured using Image J (National Institutes of Health). For each larva, multiple brain IPCs were quantified and averaged. These averaged values were then used for statistics to estimate the variance between animals under the same genetic background. Error bars represent the standard error of the mean from at least three independent experiments.

Statistics {#s13}
----------

For fly weighing, pupae volume, trehalose level, IPC cell number, ILP fluorescence intensity, and qPCR results, data were represented as mean ± SEM. Student's *t*-tests (two tailed, equal variance) were performed for statistical significance.

Results {#s14}
=======

IPC morphological changes during development {#s15}
--------------------------------------------

In preparation for laser dissection, we examined the developmental steps in the formation of IPCs to determine optimal conditions and timing for the dissection. Specification of fly brain IPCs during late embryogenesis has been characterized by several studies ([@bib106]; [@bib67]; [@bib41]), while post-specification developmental events such as neuronal morphogenesis of IPCs have been little studied. We followed the development of IPC morphology using *Ilp2-Gal4*-driven membrane (CD8) GFP ([Figure 1](#fig1){ref-type="fig"} and [File S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-7.mov), [File S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-14.mov), [File S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-5.mov), and [File S4](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-11.mov)). At early larval stages, IPCs exist as two symmetrical groups consisting of seven cells in each of the brain hemispheres. Their neuronal processes extend laterally and posteriorly within the brains, with some ending outside the brain, potentially on the aorta and the corpora cardiac compartment of the ring gland ([@bib85]) ([Figure 1](#fig1){ref-type="fig"} and [File S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-14.mov)). At later larval stages, the cell bodies increase in size and their projections extend over greater distances. During pupal stages, the processes that had extended laterally from IPCs during larval stages are gradually dismantled. The processes that initially extended posteriorly from IPCs lengthen and eventually converge into one bundle ([Figure 1](#fig1){ref-type="fig"} and [File S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-5.mov)). At later pupal stages, the two IPC clusters converge to form one cell group near the midline. During adulthood new processes beneath IPCs are formed. These extend laterally with extensive arborizations. The posterior projection bundle becomes thickened, with extensive arborization at the terminals ([Figure 1](#fig1){ref-type="fig"} and [File S4](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-11.mov)). Larval IPCs are necessary for growth control and sugar homeostasis ([@bib85]; [@bib36]). The adult IPCs, like larval IPCs, project to the corpora cardiac and to the aorta for ILP release ([@bib85]; [@bib55]; [@bib96]).

![IPC morphology changes during development. IPC neuronal structures were followed from early larval to adult stages. Developmental time points after embryo deposition are indicated. Green: *Ilp2 \> mCD8-GFP*; red: *Ilp2 \> nuclear-RFP*; blue: DAPI. up: anterior; down: posterior. Shown are maximum z-projections of confocal images taken at 1-μm step size. Flies were raised at 25° throughout development. Bar, 50 μm.](175fig1){#fig1}

In the third instar, IPCs are clustered in two symmetrically organized groups of seven neurons ([Figure 2A](#fig2){ref-type="fig"}). The neurons' structural characteristics and arrangement at this stage make them convenient for identification and laser capture. We chose early third instar larvae as the IPC source for two reasons: (1) the rapid growth during second and third instars is indicative of the need for IPC-secreted ILPs. (2) Neurite structures of IPCs do not change much during the third instar ([Figure 1](#fig1){ref-type="fig"}), making it more likely that active genes contribute to IPC-regulated ILP production rather than IPC neurite development.

![Capture of IPCs through laser microdissection. (A) *Drosophila* IPCs viewed by confocal microscopy. Green depicts IPC neuronal processes and cell bodies, and IPC cell nuclei are in red. (B) Schematic describing the cryosections that were chosen for IPC laser capture. (C) GFP-labeled IPCs before and after laser capture. Red boxes outline where IPCs are located and insets show higher magnifications of those regions. Dotted lines demarcate the boundary of the brain. Bars, 50 μm.](175fig2){#fig2}

Amplifying sequences of mRNAs extracted from laser-captured larval IPCs {#s16}
-----------------------------------------------------------------------

Frozen brain sections containing IPC cell bodies were identified using *Ilp2-Gal4 \> mCD8-GFP* and *Ilp2-Gal4 \> nuclearRFP*. During larval stages, the Ilp2-Gal4 driver is expressed at low levels in imaginal discs and at high levels in salivary glands and the 14 brain IPCs. In the brain, expression of the Ilp2-Gal4 drive is not detectable outside IPCs ([@bib12]; [@bib85]). The successful capture of IPCs was demonstrated by the absence of GFP-labeled tissue from the residual sections ([Figure 2, B and C](#fig2){ref-type="fig"}). In total, 46 IPC cell bodies from 10 brains were captured and equally divided into two groups (IPC1 and IPC2). Two samples (control 1 and control 2) of ∼100 non-IPC, non-GFP cells each were collected from the same sections from which IPCs were captured. These adjacent regions of the brain are enriched in neurons that form the superior lateral, superior medial, and ventrolateral protocerebrum, dorsolateral neurons, mushroom body, optic tubercle, and lateral horn.

The small amount of RNA isolated from laser-captured cells necessitated amplification of the RNA sequences while trying to minimally skew relative mRNA abundances. We performed two rounds of RNA amplification from each of the four initial samples. In each round of RNA amplification, poly(A)RNA was reversed-transcribed to cDNA, which was then used as template for T7-based *in vitro* transcription to produce amplified RNA ([@bib102]). One limitation of this RNA amplification method is the lower 5′ representation of amplified RNA due to inefficient reverse transcription at each round of the amplification step ([@bib10]; [@bib102]) ([Figure 3A](#fig3){ref-type="fig"}). Two rounds of amplification may be insufficient for amplifying the low-copy-number mRNA species. Despite these potential problems, this amplification strategy produces a high correlation of gene expression profiles between unamplified RNA and RNA amplified from low-input RNA (500 pg of total RNA) ([@bib101]; [@bib103]; [@bib10]; [@bib61]). To evaluate the fidelity of the LCM and RNA amplification, we used RT-PCR to verify that the major larval Ilp mRNAs were enriched in amplified samples from captured IPCs, not in laser-dissected control samples ([Figure 3B](#fig3){ref-type="fig"}).

![mRNA sequencing of IPCs and control neurons. (A) A 3′ bias of mRNA sequencing reads. Distribution of mRNA-seq reads along *Ilp3* mRNA as seen in the UCSC Genome Browser ([@bib49]). RefSeq Gene track shows *Ilp3* mRNA structure. Wide blue bar: exons; narrow blue bar: 5′ and 3′ untranslated region; blue line: intron. Distribution of mRNA reads from IPC1, IPC2, control 1, and control 2 samples is shown as black bars in individual tracks. (B) RT-PCR validation of laser-captured IPCs. *Ilp2* and *Ilp5* mRNA levels were assayed in amplified mRNAs from captured IPCs and control neural tissues. The housekeeping gene *Ribosomal protein L32* (*RpL32*) was used as control. (C) Scatter plot of the mRNA-Seq expression data of IPCs and controls. Both the *x*- and the *y*-axis represent RPKM in log~10~ ratio. Red dots highlight IPC-enriched genes. A pseudo-count of 0.01 was added to RPKMs of all genes to avoid errors in log transformation of true. Thus, zero expression genes were represented as dots with expression of −2 in log~10~ on the plot. (D) Histograms of RPKM levels of genes expressed in controls and IPCs. The *x*-axis is log~10~ scale of gene expression measured in RPKM; the *y*-axis is gene counts in log~10~ scale. A pseudo-count of 0.01 was added to RPKMs of all genes to avoid errors in log transformation of true. The dashed red line represents RPKM = 5.](175fig3){#fig3}

After aligning the sequencing reads to the reference *D. melanogaster* genome and transcriptome (dm3/BDGP Release 5 from UCSC genome browser, [Table S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-10.pdf); *Materials and Methods*) ([@bib1]; [@bib29]), we deduced the presence of transcripts representing 1851 genes that were common to both IPC samples and 2941 genes that were common to both control samples (RPKM ≥ 5.0 for moderate-to-high gene expression level) ([Figure 3, C and D](#fig3){ref-type="fig"}; [Table S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-3.xls)). The number of expressed genes (total of 3373 from IPC and control samples) is 56% fewer than the number of genes detectably represented in third instar larval whole-brain mRNA-seq data (7704 genes, or 55% of the total fly genes). The lower transcriptome representation of our laser-dissected samples may be due to (1) the mRNAs from the 46 captured IPC cells and the ∼200 captured cells presumably from a subset of the genes that are expressed in the whole brain and (2) RNA degradation during LCM and/or insufficient mRNA amplification during IPC and control sample preparation.

Comparing IPCs to the control samples from adjacent regions, 1419 genes are expressed in both. A total of 432 genes are expressed only in IPC samples (IPC1 and IPC2), and 1522 genes are expressed only in control samples (control 1 and control 2). Among the 1419 shared genes, the majority showed little variance in gene expression level between IPCs and controls; most of them are clustered around the diagonal ([Figure 3C](#fig3){ref-type="fig"}; see also [Table S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-3.xls)).

To select mRNAs that are more abundant in IPCs compared to control cells, we used the following criteria: (1) moderate-to-high expression level in IPCs (RPKM ≥5.0 in both IPC samples); (2) higher expression in IPCs than in controls for both replicates (both RPKM~IPC1~ and RPKM~IPC2~ must be greater than RPKM~Control1~ and RPKM~Control2~); (3) at least twofold enrichment of expression in IPCs compared to controls (RPKM~IPC(average)~/RPKM~Control(average)~ ≥ 2.0); and (4) a statistically significant difference between expression in IPCs and expression in controls (*P*-value ≤ 0.15 by cufflinks/cuffdiff software).

In total, we detected 193 genes that were significantly enriched in IPCs compared to controls ([Table S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-8.xls)). To identify the biological function groups represented by the IPC-enriched transcripts, we used DAVID, a gene functional classification tool (<http://david.abcc.ncifcrf.gov>). Genes were grouped into clusters based upon their gene ontology terms (GO terms) to identify genes sharing common biological functions ([Table 1](#t1){ref-type="table"} and [Table S4](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-15.xls)). Among the IPC-enriched transcripts analyzed by DAVID, the most enriched biological process cluster contains genes encoding the ILPs, G-protein-coupled receptors responding to hormone stimulation (*[Dh31-R](http://flybase.org/reports/FBgn0052843.html)*, *[CCHa2-R](http://flybase.org/reports/FBgn0033058.html)*, and *mAChR*), and other signaling transducers (*Ggamma30A*, *[Ras85D](http://flybase.org/reports/FBgn0003205.html)*, *[Hrs](http://flybase.org/reports/FBgn0031450.html)*, and *[drl](http://flybase.org/reports/FBgn0015380.html)*). Genes in this group are essential for ILP production and could be required for IPCs to sense and process upstream neuronal/hormonal signals that act on IPCs. *chico* and *[foxo](http://flybase.org/reports/FBgn0038197.html)*, both functioning in the ILP-receiving cells ([@bib11]; [@bib79]), were enriched in IPCs, suggesting a possible autocrine role for ILPs to feed back to IPCs. The second most enriched biological process cluster contains genes encoding sugar metabolic enzymes: *[Pfk](http://flybase.org/reports/FBgn0003071.html)*, *[Mdh2](http://flybase.org/reports/FBgn0262559.html)*, *[Ald](http://flybase.org/reports/FBgn0000064.html)*, *[Idh](http://flybase.org/reports/FBgn0001248.html)*, *[Mdh1](http://flybase.org/reports/FBgn0262782.html)*, *[CG9467](http://flybase.org/reports/FBgn0037758.html)*, and *[CG8460](http://flybase.org/reports/FBgn0031996.html)*. In mammalian β-cells, glucokinase and the glycolytic intermediates play important roles in glucose sensing ([@bib31]). Similarly, the enriched sugar metabolic enzymes in IPCs may participate in sugar sensing by IPCs.

###### Top-ranked biological processes represented by IPC-enriched transcripts

                                                                                   FlyBase symbol           Gene name
  -------------------------------------------------------------------------------- ------------------------ --------------------------------------------------------------
                                                                                   Enrichment score: 2.04   
  Annotation cluster 1                                                                                      
   GO\#0032868: response to insulin stimulus                                       *Ilp2*                   Insulin-like peptide 2
   GO\#0032869: cellular response to insulin stimulus                              *Ilp3*                   Insulin-like peptide 3
   GO\#0043434: response to peptide hormone stimulus                               *Ilp5*                   Insulin-like peptide 5
   GO\#0008286: insulin-receptor-signaling pathway                                 *chico*                  Insulin receptor substrate 1
   GO\#0032870: cellular response to hormone stimulus                              *Ggamma30A*              G-protein gamma 30A
   GO\#0007169: transmembrane receptor protein tyrosine-kinase-signaling pathway   *SIFa*                   IFamide
                                                                                   *Dh31*                   Diuretic hormone 31
                                                                                   *NPF*                    Neuropeptide F
                                                                                   *CCHa2-R*                CCHamide-2 receptor
                                                                                   *Dh31-R*                 Diuretic hormone 31 receptor
                                                                                   *foxo*                   Forkhead box, subgroup O
                                                                                   *mAChR*                  Muscarinic acetylcholine receptor 60C
                                                                                   *Ms*                     Dromyosuppressin
                                                                                   *Hrs*                    Hepatocyte growth-factor-regulated tyrosine kinase substrate
                                                                                   *Mip*                    Myoinhibiting peptide precursor
                                                                                   *Ras85D*                 Ras oncogene at 85D
                                                                                   *drl*                    Derailed
                                                                                   *fog*                    Folded gastrulation
                                                                                   *Adar*                   Adenosine deaminase acting on RNA
                                                                                   *pix*                    Pixie
                                                                                                            
                                                                                   Enrichment score: 1.67   
  Annotation cluster 2                                                                                      
   GO\#0006006: glucose metabolic process                                          *Pfk*                    Phosphofructokinase
   GO\#0019318: hexose metabolic process                                           *Mdh2*                   Malate dehydrogenase 2
   GO\#0005996: monosaccharide metabolic process                                   *Ald*                    Aldolase
   GO\#0006096: glycolysis                                                         *Idh*                    Isocitrate dehydrogenase
   GO\#0006007: glucose catabolic process                                          *Mdh1*                   Malate dehydrogenase
   GO\#0019320: hexose catabolic process                                           *CG9467*                 Dmel_CG9467
                                                                                   *CG8460*                 Dmel_CG8460
                                                                                   *Vha26*                  Vacuolar H\[+\]-ATPase 26kD E subunit
                                                                                   *Vha55*                  Vacuolar H\[+\]-ATPase 55kD B subunit
                                                                                   *foxo*                   Forkhead box, subgroup O
                                                                                                            
                                                                                   Enrichment score: 1.54   
  Annotation cluster 3                                                                                      
   GO\#0060538: skeletal muscle organ development                                  *unc-104*                Kinesin-like protein unc-104
   GO\#0048747: muscle fiber development                                           *Frq1*                   Frequenin 1
   GO\#0007519: skeletal muscle tissue development                                 *Gs2*                    Glutamine synthetase 2
   GO\#0014706: striated muscle tissue development                                 *Vap-33-1*               Dmel_CG5014
   GO\#0060537: muscle tissue development                                          *drl*                    Derailed
   GO\#0050808: synapse organization                                               *foxo*                   Forkhead box, subgroup O
                                                                                   *Mef2*                   Myocyte-enhancing factor 2

Each annotation cluster represents GO terms with similar biological functions determined by DAVID. Biological functional clusters were ranked based on the enrichment score. The top six GO terms that have the lowest *P*-values (most enriched) within each cluster are shown. All genes involved in each cluster are shown. Full list of the GO terms of each cluster is in [Table S5](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-6.xls).

Unexpectedly, the third cluster of enriched biological function relates to "skeletal muscle organ development" ([Table 1](#t1){ref-type="table"}). *Mef2* (**M**yocyte **e**nhancer **f**actor **2**) is the only gene that is annotated as muscle-specific, while most other genes have annotated neuronal and muscular roles, among them neuromuscular junction development. Mef2 is a transcription factor that functions in both neuron and muscle development in *Drosophila* and is required to control circadian remodeling of clock neurons ([@bib63]; [@bib89]). The majority of the genes (*unc-104*, *[Frq1](http://flybase.org/reports/FBgn0030897.html)*, *[Gs2](http://flybase.org/reports/FBgn0001145.html)*, *[drl](http://flybase.org/reports/FBgn0015380.html)*, *Vap-33-1*) in this cluster are involved in synapse assembly and/or synaptic transmission, but have a relatively lower enrichment score due to the presence of *Mef2* in the list. IPCs are neurons, so we believed that "synapse organization" is a more proper representation of genes in cluster 3. IPCs presumably required such components for organizing IPC axonal terminals and for axonal transport needed for ILP release from these neurons.

Using HomoloGene from NCBI, we searched for mammalian homologs of fly IPC-enriched genes. Of the 193 IPC-enriched genes, 109 have clear mouse homologs ([Table S5](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-6.xls)). Transcripts encoding *Drosophila* insulin-like peptides (*Ilp2*, *-3*, and *-5*) are the most enriched mRNAs in IPCs (\>4000-fold compared with control neural tissue). This confirms that IPCs were included, and enriched, among the captured cells. mRNAs from *amon* and *ia2*, which encode *Drosophila* homologs of mammalian insulin-processing enzymes ([@bib88]; [@bib82]) and insulin-secreting DCV components ([@bib35]; [@bib54]), were also enriched (8- and 11-fold) in IPCs.

Screening for conserved genes that function in fly IPCs {#s17}
-------------------------------------------------------

Using available *UAS-RNAi* lines, 50 of the 193 IPC-enriched genes were tested for their influence on growth. Transgenes that encode RNAi were engineered to be active specifically in IPCs ([Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-4.pdf)A). RNAi lines for individual genes from either the Vienna Drosophila RNAi Center (VDRC) or Transgenic RNAi Project (TRiP) collections were crossed with *Ilp2-Gal4*, and the adult progeny were examined for their weight ([@bib24]; [@bib71]) ([Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-4.pdf)A). The *Ilp2* promoter drives gene expression in IPCs starting during late embryogenesis and continuing into adulthood ([@bib85]; [@bib90]) ([Figure 1](#fig1){ref-type="fig"}). RNAi inhibition in IPCs of *amon*, *[foxo](http://flybase.org/reports/FBgn0038197.html)*, *[Rab26](http://flybase.org/reports/FBgn0086913.html)*, *unc-104*, *[hth](http://flybase.org/reports/FBgn0001235.html)*, *ald*, *Pkc98E*, *Vap-33-1*, *[Vha26](http://flybase.org/reports/FBgn0015324.html)*, and *CG13506* had strong effects on adult fly size (\>10% reduction) while inhibition of other genes had little or no effect ([Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-4.pdf)A).

A recently published mRNA-seq database for genes expressed in adult mouse β-cells was used for cross-species comparison ([@bib59]) ([Table S5](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-6.xls)). In this study, the mouse homologs of *amon*, *[foxo](http://flybase.org/reports/FBgn0038197.html)*, *Pkc98E*, *[Rab26](http://flybase.org/reports/FBgn0086913.html)*, *[Vha26](http://flybase.org/reports/FBgn0015324.html)*, *unc-104*, and *Vap-33-1* had high expression levels in pancreatic β-cells compared with other cell types. Amon is the fly homolog of mammalian proprotein convertase subtilisin/kexin type 2 (PCSK2), a processing enzyme for prohormones and neuropeptide precursors. In β-cells, PCSK2 is involved in cleavage of proinsulin to insulin and C-peptide ([@bib20]). Foxo/Foxo1 has been implicated in β-cell proliferation in the mouse pancreas ([@bib3]). In flies, Foxo functions with JNK to control Ilp transcription in response to oxidative stress ([@bib42]; [@bib105]). PRKCE, the mouse homolog of fly Pkc98E, is associated with insulin granules for exocytosis upon inositol hexakisphosphate stimulation ([@bib38]; [@bib65]). Mouse Rab37, a homolog of fly Rab26, associates with insulin-secretory vesicles based on proteome analysis ([@bib13]), but its role in insulin secretion is unknown. Unc-104/Kif1a (a kinesin-3 microtubule motor), Vha26 (a proton transport ATPase), and Vap-33-1 (vesicle-associated membrane protein) have not been implicated in insulin secretion or β-cell proliferation. We chose Unc-104, a kinesin-3 microtubule motor, for further functional analysis, based upon the strong reduction in growth when it is inhibited in IPCs ([Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-4.pdf)A).

Unc-104, a kinesin-3 family member, is required for neurite development and transporting ILP along the axons of IPCs {#s18}
--------------------------------------------------------------------------------------------------------------------

Depletion of *unc-104* mRNA from IPCs during development dramatically reduced adult size (by 27% using a VDRC line and 12% using a TRiP line) ([Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-4.pdf)A). Unc-104 was previously characterized as an anterograde motor that transports cargos, including neuropeptide-filled and synaptotagamin-bearing vesicles, in the fly nervous system ([@bib75]; [@bib9]). Insulin is packed in DCVs before release ([@bib22]; [@bib95]), so in IPCs the ILPs could be transported by Unc-104. To test this possibility, we first determined how ILPs are transported in normal IPCs.

Immunofluorescence labeling of ILP2, one of the major ILPs, together with mCD8-labeled IPC neuronal processes showed that ILP2 is localized mainly in 14 cell bodies and some of their neurites ([Figure 4A](#fig4){ref-type="fig"}). To determine whether these ILP2-positive neurites have axon and/or dendrite features, we expressed axonal (Tau) and dendritic (Khc::nod) markers ([Figure 4, B--D](#fig4){ref-type="fig"}) ([@bib83]). Tau-labeled IPC axonal bundles project contralaterally and posteriorly ([Figure 4B](#fig4){ref-type="fig"}, arrowhead), make a U-turn, and extend anteriorly (arrow) to terminals outside the brain. ILP2 resides mainly in these axonal projections ([Figure 4A](#fig4){ref-type="fig"}, white arrows; [Figure 4B](#fig4){ref-type="fig"}). The two main populations of Khc::nod-labeled dendritic arborizations extend laterally and posteriorly from the cell bodies ([Figure 4C](#fig4){ref-type="fig"}, yellow arrows). ILP2 was invisible, or at very low levels, in these neurite structures ([Figure 4A](#fig4){ref-type="fig"}, yellow arrows). The pattern of GFP-tagged DCV marker atrial natriuretic factor (ANF) in IPCs showed that DCV-carried neuropeptides are tightly associated with ILP2 granules in IPC cell bodies. This suggests that ILP2, like mammalian insulin, is packaged in DCVs for transport ([Figure 4E](#fig4){ref-type="fig"}) ([@bib22]; [@bib81]; [@bib95]). Since *Ilp2* mRNA is made in the cell bodies ([@bib12]; [@bib85]), ILP2 protein carried in DCVs is transported out of the cell bodies and along the axonal projections of IPCs.

![ILP2 is transported in DCVs along the axonal bundles in IPCs. (A) IPC neuronal structure from a third instar larval brain was labeled with *Ilp2-\>mCD8-GFP*. ILP2 localizes to some IPC neuronal projections (white arrow) but not to others (yellow arrows). (B--D) Localization of axonal (Tau) and dendritic (Khc::nod) markers in IPCs. In both figures, anterior (labeled with "A") is toward the top and posterior ("P") is toward the bottom. Arrowhead in B labels the portion of IPC axon bundles extending posteriorly from the cell bodies, and white arrow indicates, after the turn, IPC axons projecting anteriorly. Yellow arrows in C indicate the dendritic branches of IPCs. (D) Schematic of IPC polarity. (E) Localization of DCV in IPCs was examined by expressing exogenous ANF-GFP. Higher magnification of boxed region is shown for both ANF-GFP and ILP2 (single z optical section). Bars: 50 μm except in the zoomed-in image in E, where the bar represents 10 μm.](175fig4){#fig4}

Depletion of Unc-104 from IPCs during early larval developmental stages reduced the number of IPCs, disrupted IPC morphology, and imposed ∼1 day of developmental delay in adult eclosion ([Figure 5A](#fig5){ref-type="fig"}), indicating that *unc-104* is required during IPC development. Unc-104 is required for fly embryonic motor neuron synapse formation, larval synaptic terminal outgrowth, and dendrite morphogenesis of larval multidendritic neurons ([@bib75]; [@bib52]). In these past studies, a possible role of Unc-104 in insulin production would have been obscured by early developmental defects. To look specifically at Unc-104 function in ILP production, we employed *tub-Gal80^ts^* as a temporal Gal4 switch. Gal80^ts^ inhibits Gal4 until increased temperature inactivates Gal80 and allows Gal4 to trigger gene transcription, in this case transcription of a gene encoding interfering *unc-104* mRNA. We allowed Unc-104 to function through late larval development at 18°, by which time IPC neurite structure has fully developed ([Figure 1](#fig1){ref-type="fig"}), and then changed the temperature to 29° for 24 hr to induce production of *unc-104* RNAi. This strategy successfully prevented occurrence of any visible defects in IPC development ([Figure 5B](#fig5){ref-type="fig"}). In control IPCs with functional Unc-104, low-level ILP2 was detected in the cell bodies. In contrast, 24-hr depletion of *unc-104* mRNA during the second--third larval instar transition caused striking accumulation of ILP2 in IPC cell bodies, as well as enrichment of ILP2 in neurites extending from the IPC cell bodies ([Figure 5B](#fig5){ref-type="fig"}). Quantitation showed that reducing *unc-104* function in IPCs caused a twofold increase in ILP2 in the cell bodies of IPCs ([Figure 5C](#fig5){ref-type="fig"}). qPCR analysis indicated no obvious increase in brain *Ilp2* mRNA level after knockdown of *unc-104* for 24 hr ([Figure S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-9.pdf)). Thus insulin secretion was likely inhibited after depletion of *unc-104* mRNA.

![Unc-104 is localized to axons of IPCs and is required for IPC development and ILP2 secretion. (A) Control (*Ilp2 \> w^1118^*, VDRC GD line control, \#60000) and *Ilp2 \> unc-104 RNAi* (VDRC line \#23465) third instar brains were dissected. *Ilp2 \> mCD8-GFP* (green) indicates the whole IPC neural structure. (B and C) ILP2 fluorescence intensities in the brain IPC cell bodies were compared between control (*tubGal80^ts^*, *Ilp2 \> w^1118^*, VDRC GD line control, \#60000, *n* = 9 brains) and *unc-104* knockdown (*n* = 9 brains) in IPCs for 24 hr (*tubGal80^ts^*, *Ilp2 \> unc-104 RNAi*). The images were taken with the same laser settings and manipulated in the same way. IPC cell bodies are outlined in the circle in control. (D and E) Localization of Unc-104 in IPCs was examined by expressing exogenous *Unc-104-mCherry* or *Unc-104-GFP*. *Ilp2 \> mCD8-GFP* (green) indicates the whole IPC neural structure. Bars, 50 μm. Error bars: SEM, \*\**P* \< 0.01.](175fig5){#fig5}

Unc-104 is predominantly expressed in the nervous system in larval and adult flies ([@bib16]; [@bib75]). To study the role of Unc-104 in IPCs, we examined the localization of Unc-104 protein in IPCs using tagged Unc-104 produced in IPCs (*Ilp2 \> Unc-104-mCherry*, [Figure 5D](#fig5){ref-type="fig"}). Expression of this tagged Unc-104 in the nervous system is sufficient to rescue *unc-104* mutant phenotypes ([@bib75]; [@bib52]). In IPCs, Unc-104-mCherry strongly colocalized with axons ([Figure 5D](#fig5){ref-type="fig"}). Unc-104-mCherry was also in IPC dendrites, but at a much lower level compared to axons. A similar pattern of Unc-104 localization was observed when GFP-tagged Unc-104 was expressed in IPCs ([Figure 5E](#fig5){ref-type="fig"}) ([@bib9]).

When *unc-104* was depleted, ILP2 accumulated in IPC axons. The accumulation was limited to regions proximal to the cell bodies ([Figure 5B](#fig5){ref-type="fig"}, bottom). In view of the known role of Unc-104 in transporting DCVs in other neurons ([@bib75]; [@bib9]), the localization of Unc-104 in IPCs and their axonal processes is consistent with a role for the motor protein in transporting ILP2 in DCVs along axons, especially in regions proximal to the cell bodies.

IPC-specific production of Rab DN proteins identifies Rab1 as a potent growth factor and hemolymph sugar modulator {#s19}
------------------------------------------------------------------------------------------------------------------

To identify additional proteins involved in fly ILP production, 29 dominant-negative fly Rab constructs (*UAS-Rab DN*) were screened by crossing at least one line for each *Rab* gene to the *Ilp2-Gal4* driver ([@bib85]; [@bib114]). Among 43 lines tested, only IPC-specific expression of *Rab1-DN* resulted in a dramatic (\>40%) reduction in adult fly weight ([Figure 6A](#fig6){ref-type="fig"} and [Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-4.pdf)B). The other *Rab-DN* lines, including *Rab27-DN*, had little effect on fly weights when expressed in IPCs ([Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-4.pdf)B). *Rab27* is the fly ortholog of mammalian *Rab27a*, which is involved in insulin granule exocytosis ([@bib110]). In the larval brain lobes, *Rab27* is expressed in the mushroom bodies and developing antennal lobes, but not in IPCs ([@bib14]), which explains why expression of *Rab27-DN* in IPCs did not cause a growth phenotype. Expressing *Rab26-DN* in IPCs had a weaker effect on growth inhibition (7% reduction in size), compared with a 20% reduction in size achieved with *Rab26 RNAi*, suggesting that the DN construct is less effective than the RNAi construct ([Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-4.pdf)). Rab1 is expressed ubiquitously in the brain including in all 14 IPCs ([Figure 6C](#fig6){ref-type="fig"}) ([@bib14]). Producing Rab1-DN in IPCs dramatically reduced pupal size to only 61% of the controls, in keeping with the RNAi data ([Figure 6B](#fig6){ref-type="fig"} and [Figure S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-1.pdf)A).

![Rab1 is required in IPCs for normal animal growth and development. (A and B) Adult weights and pupal volume were compared between control flies (*Ilp2-Gal4 \> yw*, *n* = 153 flies, *n* = 5 pupae) and flies expressing *Rab1-DN* in IPCs (*Ilp2 \> Rab1-DN*, *n* = 138 flies, *n* = 6 pupae). (C) In a single confocal optical section, IPCs were labeled with anti-ILP2 antibody, and *Rab1*-expressed cells were labeled with *Rab1 \> Lamin-GFP*. The other IPCs that were not displayed in this optical section also expressed *Rab1*. Bar, 20 μm. (D and E) Developmental time points of the onset of metamorphosis and adult eclosion were compared between control flies and flies expressing *Rab1-DN* in IPCs. (F) Combined trehalose and glucose level in the third instar larval hemolymph was compared between control (*n* = 12 pooled hemolymph samples) and *Ilp2-Gal4 \> Rab1-DN* flies (*n* = 10 pooled hemolymph samples). Data were represented as mean ± SEM, \*\**P* \< 0.01.](175fig6){#fig6}

Reducing ILP production or secretion inhibits fly growth and developmental progression ([@bib30]; [@bib113]; [@bib34]). We tested whether inhibiting Rab1 in IPCs affects developmental timing. Flies producing Rab1-DN in IPCs eclosed and pupated, on average, ∼2 days later than control flies ([Figure 6, D and E](#fig6){ref-type="fig"}). One direct consequence of reduced ILP production or secretion is elevated levels of circulating sugars in hemolymph ([@bib85]). With larvae producing Rab1-DN in IPCs, hemolymph levels of trehalose and glucose were elevated compared to control larvae ([Figure 6F](#fig6){ref-type="fig"}). The average combined trehalose and glucose levels for control larvae and *Ilp2 \> Rab1-DN* larvae were 2372 and 2904 mg/dl, respectively. The values of carbohydrate concentration for the *Rab1-DN* larvae resembled the levels of IPC-ablated larvae ([@bib85]). This elevated sugar level, together with developmental delay and growth inhibition caused by Rab1-DN produced in IPCs, suggests that Rab1 promotes ILP production by IPCs.

Rab1 is required for IPC dendrite morphogenesis and ILP transport out of the IPC cell bodies {#s20}
--------------------------------------------------------------------------------------------

To explore the mechanism by which Rab1-DN inhibits ILP production, we first looked for any IPC developmental defects caused by constitutive inhibition of Rab1 in IPCs. IPC morphology and cell number were examined using mCD8-GFP and a RFP-conjugated nuclear marker, combined with Rab1-DN produced in the IPCs. Under these conditions, there were fewer IPCs in these larvae ([Figure 7, A and B](#fig7){ref-type="fig"}). The average IPC count was reduced from 14 ± 0.0 in wild-type larvae to 8.7 ± 0.4 in *Ilp2 \> Rab1-DN* larvae. IPC neuronal morphology was dramatically disrupted. In *Ilp2 \> Rab1-DN* larvae, dendritic arborizations were missing ([Figure 7A](#fig7){ref-type="fig"}, white arrows), while the axonal bundles were mostly intact. To specifically examine whether Rab1 controls ILP production, we employed the Gal80^ts^ stretegy described earlier to inhibit Rab1 after IPC neurite structures had fully developed. As with *unc-104* inhibition, late inhibition of Rab1 for 24 hr with the tub-Gal80^ts^ system avoided IPC developmental defects but caused a 1.6-fold increase in ILP2 level in IPC cell bodies ([Figure 7, C and D](#fig7){ref-type="fig"}). The level of ILP2 was reduced in the axonal projections that connect the IPC cell bodies, suggesting that ILP2 was trapped in cell bodies rather than transported along axons. qPCR assays indicated no obvious changes in brain *Ilp2* mRNA level after expression of *Rab1-DN* for 24 hr ([Figure S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-9.pdf)). As an alternative approach to inhibit Rab1 function, we expressed *Rab1 RNAi* using the *Ilp2-Gal4* driver. At 29°, the RNAi caused strong accumulation of ILP2 in IPC cell bodies but left IPC morphology intact ([Figure S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-1.pdf), B--D). Brains expressing *Rab1 RNAi* had the normal 14 IPCs, yet the RNAi reduced fly weight by 20%. The RNAi effect was milder than the effect of *Rab1-DN* ([Figure S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-1.pdf)A and [Figure 6A](#fig6){ref-type="fig"}). *Rab1 RNAi* in IPCs caused only a slight developmental delay (about one-half day delayed for pupation and adult eclosion) and allowed axons and dendrites of IPCs to be formed and maintained properly. There was some loss of left--right symmetry ([Figure S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-1.pdf)B), perhaps as a consequence of perturbing global growth. Despite the mild effects on development and IPC morphology, *Rab1 RNAi* caused a doubling of ILP2 accumulation in IPC cell bodies ([Figure S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.113.160663/-/DC1/genetics.113.160663-1.pdf), C and D). Both types of depletion of Rab1 function suggest a role for Rab1 in controlling intracellular trafficking of ILP2.

![Rab1 colocalizes with ILP2 granules and is required for IPC development and ILP2 transport. (A) IPC neurite structure and nuclei were labeled with *Ilp2 \> mCD8-GFP* and *Ilp2 \> nls-RFP* in third instar larval brains. (Top) The white arrows indicate the dendrites of control IPCs (*Ilp2-Gal4 \> yw*), which were missing in *Ilp2-Gal4 \> Rab1-DN* brains. (B) Quantification of IPC cell numbers (based on *Ilp2 \> nls-RFP*-labeled nuclei) indicated a reduction (five to six) in *Ilp2-Gal4 \> Rab1-DN* brains (*n* = 9 brains; for controls, *n* = 10). (C and D) ILP2 fluorescence intensities in the brain IPC cell bodies were compared between control (*tubGal80^ts^*, *Ilp2 \> yw*, *n* = 10 brains) and Rab1 inhibition (*n* = 14 brains) in IPCs for 24 hr (*tubGal80^ts^*, *Ilp2 \> Rab1-DN*). The images were taken with the same laser settings and manipulated in the same way. (E) Labeling of Rab1 (*Ilp2 \> Rab1-YFP*), a Golgi marker (*Ilp2 \> Grasp65-GFP*), or an endosome marker (*Ilp2 \> FYVE-GFP*) in combination with ILP2 staining. The left column (bottom magnification) shows the localization of GFP/YFP-tagged proteins as a projection of z-stacks. Rab1- and FYVE-labeled endosomes were localized almost exclusively in the cell bodies, while Grasp65-labeled *cis*-Golgi distributed in both the IPC cell bodies and the axons. Boxed regions are shown in higher magnification in the right columns. Rab1-YFP, Grasp-GFP, FYVE-GFP, and ILP2 all had punctate localization patterns in IPCs. For examination of colocalization between vesicles/granules, single z optical sections were shown. Bars, 50 μm except in the zoomed-in images in E, where the bar represents 10 μm. Error bars: SEM, \*\**P* \< 0.01.](175fig7){#fig7}

When Rab1 is inhibited in IPCs, ILP secretion is inhibited during transit from cell bodies to the axonal tracts. To investigate whether Rab1 directly influences ILP transport in IPCs, ILP2 was labeled with antibodies in wild-type IPCs expressing Rab1-YFP. Rab1-YFP was localized within IPC cell bodies with very low fluorescence in IPC axons or dendrites ([Figure 7E](#fig7){ref-type="fig"}). Rab1-YFP and ILP2 immunofluorescent labeling displayed punctate patterns in IPC cell bodies. Strikingly, the majority of ILP2 punctae overlapped with Rab1 punctae, suggesting that Rab1-containing vesicles directly transport ILP granules along the route of ILP secretion.

Rab1 controls ER-to-Golgi transport ([@bib93]), so we investigated whether ILP2 granules reside in the Golgi. Producing the GFP-labeled Golgi marker Grasp65 in IPCs revealed punctate Golgi patterns that colocalized with ILP2 granules ([Figure 7E](#fig7){ref-type="fig"}). As a negative control, the endosome marker FYVE-GFP was produced in IPCs. The FYVE-labeled endosomes were in a punctate pattern, like Grasp65-GFP and Rab1-YFP, but had few overlaps with ILP2 granules. These data, together with the elevated ILP levels in IPCs after Rab1 inhibition, suggested that ILP is delivered by Rab1 to the Golgi in IPC cell bodies. The failed delivery of ILPs outside the cell bodies, due to Rab1 inhibition, results in failed secretion.

Discussion {#s21}
==========

*Drosophila* brain IPCs regulate development, growth, metabolism, stress resistance, life span, feeding, locomotor activity, olfactory sensitivity, sleep, and ethanol sensitivity in response to internal physiological and external nutritional signals ([@bib69]). Until now, only a handful of genes were known to function in IPCs. By combining LCM, RNA-seq, two *UAS-RNAi* libraries, and our *UAS-Rab-DN* collection, we systematically screened for genes that are important for IPC function. Among genes that rendered IPC-specific phenotypes when inhibited in IPCs, we focused on *unc-104* and *Rab1* and investigated their roles in ILP secretion and IPC development.

Conservation between mammalian pancreatic β-cells and fly IPCs {#s22}
--------------------------------------------------------------

Among the neurons, glial cells, intestinal muscle cells, adipocytes, and salivary gland cells that can produce ILPs in flies ([@bib12]; [@bib43]; [@bib67]; [@bib74]; [@bib15]; [@bib72]; [@bib91]), brain IPCs are the best-characterized. Several lines of evidence indicate that *Drosophila* brain IPCs and mammalian pancreatic β-cells share functional and physiological similarities: (1) Genetic ablation of fly IPCs or deletion of fly ILPs results in metabolic phenotypes similar to mammals with β-cell/insulin deficiency ([@bib12]; [@bib43]; [@bib85]; [@bib113]; [@bib34]). (2) Fly ILPs and mammalian insulin carry out their functions by activating a conserved signaling pathway in target tissues ([@bib8]). (3) In *Drosophila*, brain IPCs and adipokinetic hormone-producing cells are physically connected through neuronal projections and in this sense at least are functionally analogous to pancreatic β- and α-cells ([@bib55]). (4) β-Cells and fly IPCs respond to Leptin/Leptin-like cytokine secreted from adipose tissue to regulate ILP release ([@bib53]; [@bib80]).

Phylogenetic analyses of insulin-producing cells suggest that mammalian β-cells and fly IPCs have common evolutionary origins or have different origins but have undergone convergent evolution ([@bib4]). Mammalian β-cells arise from the endoderm ([@bib47]), and fly IPCs are neurons arising from the ectoderm ([@bib106]). Fly IPCs have long axons requiring extensive transport of vesicles, while β-cells have no axons. Yet phylogenic analyses of insulin-expressing cells indicate that neurons evolved to secrete insulin before there were β-cells, creating a puzzle about the evolutionary origin of β-cells ([@bib4]). In jellyfish, insulin is produced only by neurons ([@bib21]). In *Caenorhabditis elegans* and in *Drosophila*, insulin is produced by neurons and by endoderm-derived cells ([@bib12]; [@bib85]; [@bib62]). The insulin-producing cells in a worm's nervous system and intestine respond to food intake to control development, life span, and stress resistance ([@bib62]; [@bib44]).

Pancreatic β-cells have some similarities to neurons. From the perspective of physiology, (1) β cells and neurons pack their signaling peptides into secretory granules and release them using action potentials ([@bib84]). (2) Hypothalamic neurons can sense blood glucose levels ([@bib60]), as β-cells do. From the perspective of gene expression, (1) β-cells express certain "neural-specific" genes, which encode sodium channels, neurofilaments, neurotransmitters (such as GABA), and their receptors ([@bib28]; [@bib78]; [@bib32]; [@bib2]; [@bib108]). (2) Neurons and β-cells do not express the gene encoding the neuron-restrictive silencing factor/repressor silencing transcription factor, a negative regulator of neuron fate that is made only in non-neuronal cells ([@bib5]). For all these reasons, β-cells and insulin-expressing neurons may share properties and proteins useful for controlling insulin production and secretion.

By analyzing the IPC transcriptome using LCM and mRNA sequencing, we found a group of IPC-enriched mRNAs that are orthologs of mammalian genes active during insulin production and secretion. Larval-stage-specific *Ilp*s (*Ilp2*, *Ilp3*, and *Ilp5*) were found, as expected, and we detected enrichment of *amon*, *ia2*, and *Pkc98E* mRNAs, which encode *Drosophila* orthologs of key mammalian insulin-processing enzymes, DCV components, and signal transducers that control insulin secretion ([@bib87]; [@bib88]; [@bib38]; [@bib65]; [@bib26]; [@bib82]). Many other IPC-enriched genes have mouse orthologs that are preferentially transcribed in pancreatic β-cells ([@bib59]). This provided good evidence that our captured samples were highly enriched in IPCs and strengthened the evidence for conservation between fly IPCs and mammalian β-cells. Functional tests indicated that at least 20% (10 of 50) of the IPC-enriched genes that have mammalian orthologs are required in IPCs for proper *Drosophila* body size to be attained. RNAi with expression of any of these genes in IPCs strongly (\>10%) reduced growth. Therefore, the combination of LCM and RNA-seq is a powerful and sensitive method for characterizing the transcriptome of a specific cell type, such as IPCs, that is present in limited cell numbers in the brain.

In addition to ILPs, four neuropeptide genes were enriched in our IPC samples: *[Myoinhibiting peptide precursor](http://flybase.org/reports/FBgn0036713.html)* (*[Mip](http://flybase.org/reports/FBgn0036713.html)*), *Dromyosuppressin* (*Dms*), *[neuropeptide F](http://flybase.org/reports/FBgn0027109.html)* (*npf*), and *IFamide* (*IFa*). These may be contaminants from adjacent cells ([@bib76]). Since our starting materials were only 23 captured cells for each IPC sample, if one of the neuropeptide mRNAs is at a higher level (*e.g.*, \>100-fold) compared to average brain cells, it may have been purified along with IPC mRNAs. Since we used third instar larval IPCs for transcriptome analysis, mRNAs for G-protein-coupled receptors, membrane channels, and transporter proteins that are abundant in IPCs earlier in development may not be present among our enriched mRNAs. Larvae undergo developmental transitions in the third instar stage that require ecdysone and involve metabolic changes. By capturing gene expression during that time we sampled a larger range of cell properties and conditions than doing the same analysis of adult IPCs.

IPC neuronal polarity and neurite development {#s23}
---------------------------------------------

Our studies and prior work suggest that ILP2 is synthesized in IPC cell bodies and transported out of the cell bodies mainly along Tau-labeled axonal projections to IPC axonal terminals, where ILP2 is released ([@bib12]; [@bib43]; [@bib85]; [@bib23]; [@bib30]). ILP2 is also released within the brain ([@bib6]). By following IPCs during larval development, we observed that IPC axons and dendrites extend over greater distances until the early third instar larval stage. The neurite extension of IPCs is required to compensate for the size increase of brain lobes, so that connections between IPCs and other brain regions such as subesophageal ganglion are maintained ([@bib85]; [@bib23]). IPC dendrite extension and more extensive dendritic arborization might also be required to form new neuronal connections with other neurons, thus adjusting to new developmental and physiological needs.

Unc-104 in ILP transport in IPCs {#s24}
--------------------------------

Two regulators of ILP production, Unc-104 and Rab1, emerged as the strongest regulators from our screens. Strict regulation of ILP secretion is required to adjust downstream insulin signaling to food availability and metabolic status. Precise control is achieved through regulatory steps in IPCs: sensing of neuronal or hormonal signals, control of ILP secretion machinery by the signals, directed transport of ILPs to the IPC axonal terminal, and final release of ILP out of IPCs. Based upon our experiments, both Unc-104 and Rab1 are involved in directed transport of ILPs.

Unc-104 in worms and flies, and its mammalian homolog Kif1a, are anterograde motor proteins that transport DCVs along axons ([@bib73]; [@bib112]; [@bib75]; [@bib9]; [@bib64]). DCVs exist in different cell types. In neurons, DCVs are responsible for transporting, processing, and secreting neuropeptide cargos. In pancreatic β-cells, insulin is packed into DCVs. The movement and secretion of insulin-containing DCVs to β-cell surfaces is a Ca^2+^-dependent process that requires kinesin heavy chain movement along microtubules ([@bib66]; [@bib25]; [@bib19]). It is currently unknown whether other kinesin family proteins contribute to insulin-containing DCV movement and secretion. Our study shows that a kinesin 3 family protein, Unc-104, transports insulin granules along the axons of IPCs. ILP2 colocalizes with DCVs in IPC cell bodies. We observed Unc-104 and ILP2 distributed along IPC axons. Reducing *unc-104* function using two different small interfering RNAs (siRNAs) caused accumulation of ILP2 in cell bodies and in their proximal axonal projections. Consistent with a role for fly Unc-104 in transporting insulin-like peptides, *C. elegans* Unc-104 transports fluorescently tagged insulin-like protein 22 and IA-2 in motor neurons ([@bib33]). Mammalian *Kif1a*'s role in insulin transport and secretion has not been reported. *Kif1a* mutant mice die soon after they are born due to severe motor and sensory defects ([@bib111]). They exhibit defects in the localization of synaptic vesicle precursors. Whether newborn *Kif1a* mutant mice have diabetic symptoms has not been reported.

Rab1 in ILP transport in IPCs {#s25}
-----------------------------

The small GTPase Rab1 regulates membrane trafficking within early Golgi compartments and in the ER--Golgi transition. In *Drosophila*, Rab1 was first described as a contributor in the maintenance of photoreceptor cell structure by mediating vesicle transport between the rough ER and Golgi body ([@bib86]). Our study shows that Rab1 is expressed ubiqutously in the fly brain, including IPCs. The specific effect with only *Rab1-DN* but not other *Rab-DN*s when expressed in IPCs shows that Rab1-DN interferes specifically with endogenous Rab1 function. It also rules out an alternative interpretation that Rab1-DN titrates some endogenous protein such as a GEF that works on multiple Rabs, one of which is the real regulator, in addition to Rab1. Inhibiting Rab1 function through dominant-negative or siRNA constructs caused accumulation of ILP2 in cell bodies and substantially reduced ILP2 in IPC axons. YFP-tagged Rab1 is localized predominantly in the cell bodies and exhibits a tight association with ILP2 granules cytologically. A recent study of the silkworm *Bombyx mori* showed that Rab1 is restricted to a small number of neurons in the brain, where it colocalizes with Bombyxin, an insulin family peptide, in the pars intercerebralis area ([@bib100]). Proteomic analysis showed that Rab1 is enriched in immunopurified β-cell insulin granules ([@bib37]). Rab1 may be conserved as a critical molecule needed for insulin production.

Unc-104 and Rab1 in IPC development {#s26}
-----------------------------------

In addition to their roles in ILP production, Unc-104 and Rab1 are required for IPC development. Constitutive depletion of *unc-104* mRNA from IPCs using *Ilp2-Gal4* resulted in severe disruption of IPC axons and dendrites and dramatically reduced IPC cell numbers as detected by *Ilp2 \> mCD8-GFP*. Since IPCs are post-mitotic neurosecretory cells and *Ilp2* mRNA is produced only after IPC differentiation ([@bib106]; [@bib41]), *Ilp2-Gal4*-driven *unc-104 RNAi* does not interfere with the initial formation and specification of IPCs during late embryogenesis. Therefore, the observed reduction in IPC cell numbers at late larval stages comes from cell death during larval development. This phenotype is consistent with the observation that *Kif1a* mutant mice, and cultures of *Kif1a* mutant neurons, exhibit marked neuronal degeneration and death, which could be caused by insufficient neural stimulation due to disrupted neural connections ([@bib111]). Given the roles that Unc-104 plays in fly motor neuron and multidendritic neuron development ([@bib75]; [@bib52]), the axonal and dendritic morphology disruption seen in IPCs could be an initial neurite outgrowth defect, a later maintenance defect, or a combination of both.

We have found that constitutive inhibition of *Rab1* in IPCs, using a dominant-negative protein, resulted in disruption of IPC dendrites to a lesser extent than *unc-104 RNAi*. Rab1 functions in ER-to-Golgi transport, so this preferential disruption of IPC dendrites over IPC axons could be explained if IPC dendrites, like those of fly "da" neurons and rodent hippocampal neurons, are more sensitive to the reduction of ER-to-Golgi transport than IPC axons ([@bib109]). *Rab1-DN* induced cell death during IPC development, although less severely than *unc104 RNAi*. The milder phenotypes with respect to neuron viability and neurite morphology in IPCs producing *Rab1-DN* compared to IPCs expressing *unc-104 RNAi* are consistent; a milder defect in neurite morphology may underlie a milder defect in neuron viability. Alternatively, Rab1-DN might cause accumulation of cytotoxic components such as misfolded α-synucleins in IPCs, which could underlie the loss of IPCs ([@bib18]).

Proteins like Rab1 and Unc-104 have multiple functions in a variety of cell types. Using cell-type-specific interference, we have explored their roles in production and transport of insulin-like peptides and determined the cellular and whole-organism phenotypes associated with their damaged functions. These proteins join an important list of critical factors needed for the controlled production and release of insulin-family proteins.
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